Announcements Trials
Browse Landscape

Phase

Phase 1/2 1Phase 1 1

Status

Completed 1Active not recruiting 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Dermatologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 70Squamous Cell Carcinoma of Head and Neck 32Parkinson Disease 4, Autosomal Dominant Lewy Body 30Lung Neoplasms 28Melanoma 24Triple Negative Breast Neoplasms 23Neoplasms 20Neoplasm Metastasis 20Breast Neoplasms 19Colorectal Neoplasms 18Head and Neck Neoplasms 15Endometrial Neoplasms 15Ovarian Neoplasms 14Carcinoma, Renal Cell 13Urinary Bladder Neoplasms 11Carcinoma, Transitional Cell 10Pancreatic Neoplasms 7Hodgkin Disease 7Esophageal Neoplasms 7Uterine Cervical Neoplasms 6Sarcoma 6Recurrence 6Lymphoma 6Carcinoma 6Stomach Neoplasms 4Small Cell Lung Carcinoma 4Prostatic Neoplasms 4Multiple Myeloma 4Mouth Neoplasms 4Lymphoma, Large B-Cell, Diffuse 4

Interventions

pembrolizumab 2tremelimumab 1poly ICLC 1lenvatinib 1durvalumab 1balstilimab 1Peptides 1Pemetrexed 1Carboplatin 1Blood Specimen Collection 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Diabetes Mellitus, Insulin-Dependent, 12 × pembrolizumab × 30 days × Clear all
NCT04305054 2026-05-28

KEYMAKER-U02

Merck Sharp & Dohme LLC

Phase 1/2 Completed
335 enrolled
Dermatologic

Diabetes Mellitus, Insulin-Dependent, 12, Parkinson Disease 4, Autosomal Dominant Lewy Body, Melanoma

NCT03530397 2026-05-19

A Study to Evaluate MEDI5752 in Subjects With Advanced Solid Tumors

MedImmune LLC

Phase 1 Active not recruiting
400 enrolled

Diabetes Mellitus, Insulin-Dependent, 12, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡